Diabetic

An oral pill would be much easier for diabetics than daily insulin injections. An experimental new method for packing insulin into capsules helps it survive the trip through the stomach to the bloodstream, and releases its payload only when needed.

A new systematic review and meta-analysis published in the British Medical Journal has concluded adhering to a low-carbohydrate diet for six months is the most effective dietary strategy to put type type 2 diabetes into remission.

An incredible proof-of-concept study has demonstrated the development of a novel insulin molecule that can sense blood sugar levels and self-adjust its activity in response to a patient’s needs, raising hopes of a safer and easier insulin therapy.

The promising results of a Phase 2 trial testing a new, once-weekly insulin treatment for type 2 diabetes have been published. The weekly injection was found to be as safe and effective as daily insulin shots and a larger Phase 3 trial is currently being planned.

The brain may be a new drug target for longer term control of diabetes. Two new studies on rodents have investigated how a certain peptide works to induce remission for animals with diabetes, which could lead to new breakthroughs in human treatments.

Researchers have developed an ultrafast-acting form of insulin that promises to work up to four times faster than current formulations. The novel drug has only been tested in animals so far but the researchers hope to test it in human trials soon.

Imagine a device that lets people with diabetes use an app to give themselves a boost of insulin when they need it, without an injection. A prototype device can do just that, using electricity to control gene expression in encapsulated beta cells.

Researchers have developed a novel technique that combines two diabetes drugs into a single injection. Previously these compounds required separate injections, creating a barrier for treatment that led to few diabetics embracing the novel therapy.

Orally administered insulin, a game-changing treatment, is one step closer to reality with a final Phase 2b human clinical trial underway to prove the drug's efficacy before it reaches the final stages of trials and registrations that could bring it to market within a few short years.

Diabetics are often warned against the dangers of eating too much chocolate. But it turns out that one of the treat's major components might be just the thing to help keep the disease at bay. Researchers have isolated a compound in cocoa pushes certain cells to become insulin powerhouses.

Finger-prick tests to monitor blood glucose levels can be the bane of a diabetic's life. In a move that could put an end to such tests in the future, researchers at Princeton University have developed a non-invasive way to test blood glucose levels using a laser.

Scientists are developing a biochip that could be used by diabetics to measure glucose levels in their saliva.